Dogwood Therapeutics, Inc. Common Stock
Symbol: DWTX (NASDAQ)
5.67
▲ (0.62%) 0.035
Company Description:
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Key Stats
- Today's Open: $5.9
- Today's High: $5.9
- Today's Low: $5.48
- Today's Volume: 1.11K
- Yesterday Close: $5.63
- Yesterday High: $6.13
- Yesterday Low: $5.63
- Yesterday Volume: 40.96K
- Last Min Volume: 4
- Last Min High: $5.665
- Last Min Low: $5.665
- Last Min VWAP: $5.665
Company Profile
- Name: Dogwood Therapeutics, Inc. Common Stock
- Website: https://www.virios.com
- Listed Date: 2020-12-17
- Location: ALPHARETTA, GA
- Market Status: Active
- CIK Number: 0001818844
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $14.19M
- Round Lot: 100
- Outstanding Shares: 2.29M
- Asset Type: CS
RECENT FILINGS FOR DWTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-20 | DEF 14A | View |
| 2025-10-16 | S-3/A | View |
| 2025-10-09 | DEFA14A | View |
| 2025-10-09 | 8-K | View |
| 2025-10-08 | PRE 14A | View |
| 2025-10-01 | S-3 | View |
| 2025-09-29 | DEFA14A | View |
| 2025-09-29 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-07-02 | 8-K | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-26 | S-8 | View |
Latest News on DWTX